Early acute cellular rejection: no effect on late hepatic allograft function in man

Area of Science:

• Hepatology
• Transplantation immunology
• Organ transplantation

Background:

• Early acute cellular rejection (ACR) impacts kidney and heart transplant outcomes.
• Limited quantitative data exists on ACR's long-term effects in liver transplantation.
• Understanding ACR's impact is crucial for optimizing liver allograft management.

Purpose of the Study:

• To prospectively evaluate the long-term effects of early acute cellular rejection on liver allograft function one year post-transplantation.
• To compare liver function, liver cell mass, and metabolic capacity in liver transplant recipients with and without a history of ACR.
• To determine if early ACR episodes influence late graft function in liver transplant recipients.

Main Methods:

• Prospective study of 37 consecutive liver transplant patients one year post-transplantation.
• Assessment of routine liver function tests, galactose elimination capacity (GEC) for liver cell mass, and aminopyrine breath test (ABT) for metabolic capacity.
• Comparison between 19 patients with biopsy-proven ACR and 18 patients without ACR.

Main Results:

• The majority of patients had normal functioning liver cell mass and microsomal metabolic capacity.
• No significant differences in GEC or ABT were observed between patients with and without prior ACR.
• Early ACR episodes did not correlate with impaired liver allograft function at one year.

Conclusions:

• Early acute cellular rejection episodes do not adversely affect the late function of human liver allografts.
• Liver allograft function, assessed by liver cell mass and metabolic capacity, remains unaffected by early ACR.
• Findings contrast with the known impact of early ACR on kidney and heart transplants, suggesting unique immunological responses in liver grafts.